Quarterly report pursuant to Section 13 or 15(d)

NOTES PAYABLE (Details)

v3.22.2.2
NOTES PAYABLE (Details)
$ / shares in Units, $ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2022
USD ($)
Equity_Instrument
$ / shares
Dec. 31, 2021
USD ($)
Equity_Instrument
$ / shares
Debt Instrument [Line Items]    
Principal Outstanding $ 27,023 $ 22,339
Unamortized Discount 3,696 4,332
Carrying Amount $ 23,326 $ 18,007
Underlying Shares Notes | Equity_Instrument 41,062,535 10,173,099
2013 Notes payable [Member]    
Debt Instrument [Line Items]    
Interest rate 10.00% 10.00%
Term of Notes Due on demand Due on demand
Principal Outstanding $ 734 $ 869
Carrying Amount $ 734 $ 869
2021 Notes payable [Member]    
Debt Instrument [Line Items]    
Interest rate 11.00% 11.00%
Term of Notes Due on demand Due on demand
Term of Notes 2 years 2 years
Principal Outstanding $ 2,793 $ 3,030
Carrying Amount $ 2,793 3,030
2022 Notes payable [Member]    
Debt Instrument [Line Items]    
Term of Notes Due on demand  
Term of Notes 10 months  
Principal Outstanding $ 2,985  
Unamortized Discount 118  
Carrying Amount $ 2,867  
2022 Notes payable [Member] | Minimum [Member]    
Debt Instrument [Line Items]    
Interest rate 11.00%  
2022 Notes payable [Member] | Maximum [Member]    
Debt Instrument [Line Items]    
Interest rate 41.00%  
Notes Payable [Member]    
Debt Instrument [Line Items]    
Principal Outstanding $ 6,512 3,899
Unamortized Discount 118  
Carrying Amount 6,394 3,899
Principal Outstanding, Current 6,512 2,399
Unamortized Discount, Current 118  
Notes payable, current $ 6,394 2,399
Principal Outstanding, Non Current   1,500
Notes payable, non-current   $ 1,500
2020 Notes payable - related parties [Member]    
Debt Instrument [Line Items]    
Interest rate 12.00% 12.00%
Term of Notes Due on demand Due on demand
Principal Outstanding $ 100 $ 100
Carrying Amount $ 100 $ 100
2021 Notes payable - related parties [Member]    
Debt Instrument [Line Items]    
Interest rate 12.00% 12.00%
Term of Notes Due on demand Due on demand
Principal Outstanding $ 700 $ 700
Carrying Amount $ 700 700
2022 Notes payable - related parties [Member]    
Debt Instrument [Line Items]    
Term of Notes Due on demand  
Principal Outstanding $ 2,071  
Carrying Amount $ 2,071  
2022 Notes payable - related parties [Member] | Minimum [Member]    
Debt Instrument [Line Items]    
Interest rate 10.00%  
2022 Notes payable - related parties [Member] | Maximum [Member]    
Debt Instrument [Line Items]    
Interest rate 12.00%  
Notes payable - related parties [Member]    
Debt Instrument [Line Items]    
Principal Outstanding   800
Carrying Amount   800
Principal Outstanding, Current $ 2,871 800
Notes payable, current $ 2,871 $ 800
2021 Convertible Notes Payable [Member]    
Debt Instrument [Line Items]    
Interest rate 2.00% 2.00%
Term of Notes 3 years 3 years
Term of Notes 3 years 3 years
Conversion Price | $ / shares [1] $ 0.37 $ 1.48
Principal Outstanding $ 14,490 $ 14,490
Unamortized Discount 3,578 4,332
Carrying Amount $ 10,912 $ 10,158
Underlying Shares Notes | Equity_Instrument 40,739,519 9,856,343
Convertible Notes Payable [Member]    
Debt Instrument [Line Items]    
Principal Outstanding $ 17,640 $ 17,640
Unamortized Discount 3,578 4,332
Carrying Amount $ 14,062 $ 13,308
Underlying Shares Notes | Equity_Instrument 41,062,535 10,173,099
Principal Outstanding, Current $ 17,640 $ 14,490
Unamortized Discount, Current 3,578 4,332
Notes payable, current $ 14,062 $ 10,158
Underlying Shares Notes, Current | Equity_Instrument 41,062,535 9,856,343
Principal Outstanding, Non Current   $ 3,150
Notes payable, non-current   $ 3,150
Underlying Shares Notes, Non Current | Equity_Instrument   316,756
2020 Convertible Notes Payable [Member]    
Debt Instrument [Line Items]    
Interest rate 12.00% 12.00%
Term of Notes 3 years 3 years
Term of Notes 3 years 3 years
Conversion Price | $ / shares [2] $ 10.00 $ 10.00
Principal Outstanding $ 3,150 $ 3,150
Carrying Amount $ 3,150 $ 3,150
Underlying Shares Notes | Equity_Instrument 323,016 316,756
[1]

The notes are convertible into Emmaus Life Sciences, Inc. shares. Beginning February 28, 2022, the note holders became entitled to call for early redemption of the convertible notes payable, because the Company common stock was not approved for listing on a Trading Market (as defined in the agreement). Accordingly, the notes are classified as current liabilities.

[2] This note is convertible into shares of EMI Holding, Inc., a wholly owned subsidiary of Emmaus Life Sciences, Inc.